Johnson Matthey PLC (LON:JMAT) Insider Liam Condon Acquires 30 Shares

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon bought 30 shares of Johnson Matthey stock in a transaction on Wednesday, January 22nd. The shares were purchased at an average cost of GBX 1,362 ($16.82) per share, for a total transaction of £408.60 ($504.69).

Johnson Matthey Price Performance

Shares of JMAT opened at GBX 1,367 ($16.88) on Friday. The company has a debt-to-equity ratio of 63.15, a current ratio of 1.45 and a quick ratio of 0.76. The company has a market cap of £2.38 billion, a P/E ratio of 2,356.90, a PEG ratio of 49,242.50 and a beta of 0.95. Johnson Matthey PLC has a 12 month low of GBX 1,295.54 ($16.00) and a 12 month high of GBX 1,917.07 ($23.68). The stock has a fifty day moving average price of GBX 1,381.47 and a 200 day moving average price of GBX 1,510.98.

Johnson Matthey (LON:JMATGet Free Report) last announced its quarterly earnings results on Wednesday, November 27th. The company reported GBX 57.40 ($0.71) EPS for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.39%. On average, research analysts forecast that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.

Johnson Matthey Cuts Dividend

The company also recently announced a dividend, which will be paid on Tuesday, February 4th. Shareholders of record on Thursday, December 5th will be given a GBX 22 ($0.27) dividend. The ex-dividend date is Thursday, December 5th. This represents a yield of 1.47%. Johnson Matthey’s dividend payout ratio (DPR) is 13,275.86%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on JMAT. Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.23) target price on shares of Johnson Matthey in a research note on Tuesday, December 17th. Berenberg Bank lowered their price objective on shares of Johnson Matthey from GBX 1,650 ($20.38) to GBX 1,500 ($18.53) and set a “hold” rating for the company in a research report on Thursday, November 28th.

Get Our Latest Stock Report on Johnson Matthey

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Articles

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.